Price T Rowe Associates Inc Astrazeneca PLC Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 64,939,661 shares of AZN stock, worth $5.17 Billion. This represents 0.61% of its overall portfolio holdings.
Number of Shares
64,939,661
Previous 61,271,974
5.99%
Holding current value
$5.17 Billion
Previous $4.15 Billion
22.01%
% of portfolio
0.61%
Previous 0.51%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Primecap Management CO Pasadena, CA42.6MShares$3.39 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.23 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.92 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.4 Billion0.44% of portfolio
-
Jennison Associates LLC17MShares$1.35 Billion0.85% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $247B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...